Hetrombopag: all 52 studies that test it

Page 1 of 1. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal TumorsRecruitingNCT07492693Phase 2
• A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor TherapyNot yet recruitingNCT07408648Phase 2
• A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.Not yet recruitingNCT07334093Phase 2
• A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia (ExCIT)RecruitingNCT07286032Phase 3
• Herombopag Treated T-DM1 Induced Platelet ReductionRecruitingNCT07257809Phase 2
• A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal CarcinomaNot yet recruitingNCT07252375Phase 2
• Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 StudyNot yet recruitingNCT07243418Phase 2
• Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With HerombopagNot yet recruitingNCT07198672Not applicable
• A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer TherapyNot yet recruitingNCT07101627Phase 2
• A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITPRecruitingNCT06838949Phase 2
• Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With NeuroblastomaRecruitingNCT06818916Not applicable
• Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical CancerNot yet recruitingNCT06745219Phase 2
• Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of ThrombocytopeniaRecruitingNCT06562738Phase 4
• TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment TerminationRecruitingNCT06478537Phase 2
• Hetrombopag for the Thrombocytopenia Induced by Concurrent ChemoradiotherapyRecruitingNCT06433830Phase 2
• Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects.Not yet recruitingNCT06346925Phase 1
• The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic MalignanciesNot yet recruitingNCT06099925Phase 2
• Study of the Food Effects of Herombopag Olamine Tablets in Healthy SubjectsNot yet recruitingNCT06062680Phase 1
• The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer PatientsNot yet recruitingNCT06036966Phase 2
• Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in LymphomaNot yet recruitingNCT05969158Phase 2
• Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia(CIT) in Patients With Acute Myeloid LeukemiaNot yet recruitingNCT05944211Phase 2
• Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before HepatectomyRecruitingNCT05442632Phase 2
• Herombopag for Chemotherapy-induced ThrombocytopeniaRecruitingNCT05236582Phase 2
• Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.Active, not recruitingNCT05864014Phase 3
• Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT05727917Not applicable
• Extension Study of Herombopag for Pediatric Patients With Chronic Immune ThrombocytopeniaStatus unknownNCT05685420Phase 3
• Herombopag Added to Cyclosporine in Non Severe Aplastic AnemiaCompletedNCT05660785Phase 2
• Herombopag Olamine in the Treatment of Thrombocytopenia After ChemotherapyStatus unknownNCT05575986Phase 4
• A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast CancerCompletedNCT05394285Phase 2
• Hetrombopag for Lower-risk MDS With Thrombocytopenia: a Prospective，Open-label, Single-arm Study.Status unknownNCT05392647Phase 2
• Herombopag + rhTPO in Severe Immune ThrombocytopeniaStatus unknownNCT05328804Phase 3
• A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced ThrombocytopeniaWithdrawnNCT05261646Phase 3
• An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLCStatus unknownNCT05252091Phase 2
• A Bioequivalence Study of Hetrombopag in Healthy SubjectsCompletedNCT05088655Phase 1
• A Trial of Hetrombopag in Healthy and Hepatic Impairment SubjectsCompletedNCT05088642Phase 1
• Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy SubjectsCompletedNCT05088343Phase 1
• Hetrombopag for Low/Intermediate-1 Risk MDS With ThrombocytopeniaStatus unknownNCT05024877Phase 2/3
• Efficacy and Safety of Hetrombopag in Non-severe Aplastic AnemiaWithdrawnNCT05018936Phase 2/3
• Extension Study of Hetrombopag in Severe Aplastic AnemiaActive, not recruitingNCT04961710Phase 3
• Hetrombopag for Pediatric Patients With Chronic Immune ThrombocytopeniaCompletedNCT04737850Phase 3
• A Trial of SHR8735 in Healthy SubjectsCompletedNCT04701216Phase 1
• Relative Bioavailability of Early Phase and Late Phase Hetrombopag Olamine FormulationsCompletedNCT04688008Phase 1
• Metabolism and Disposition of [14C] Herombopag in Chinese Healthy Human SubjectsCompletedNCT03977805Phase 1
• Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.CompletedNCT03976882Phase 3
• Hetrombopag or Placebo in Treatment-Naive Severe Aplastic AnemiaCompletedNCT03825744Phase 3
• A Study to Evaluate Different Intervals Between Dosing and Feeding on the PharmacokineticsCompletedNCT03603132Phase 1
• A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia （SAA） PatientCompletedNCT03557099Phase 1/2
• Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) PatientCompletedNCT03222843Phase 3
• Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) PatientsStatus unknownNCT02614846Phase 1
• Effect of a High-fat Meal on the Pharmacokinetics of Hetrombopag and Mass Balance Study in Healthy SubjectsCompletedNCT02409394Phase 1
• A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) PatientsStatus unknownNCT02403440Phase 1
• A Phase I Study of Hetrombopag Olamine in Healthy Adult VolunteersCompletedNCT01830660Phase 1

← Hetrombopag overview